GleamWall
中文EN

INBS INTELLIGENT BIO SOLUTIONS INC.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1725430 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2026Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY57.2%
TTM net income YoY-11.4%
TTM EPS YoY74.6%
Revenue 3-yr CAGR27.6%
Net income 3-yr CAGR—

Margins

Gross margin50.9%
Operating margin-272.2%
Net margin-269.3%
FCF margin—
EBITDA margin-246.5%

Returns

ROE-216.1%
ROA-102.3%
ROIC (approx.)-534.9%
Asset turnover0.38x

Leverage & solvency

Liabilities / assets46.0%
Debt / equity0.00x
Current ratio1.98x
Interest coverage-187.68x

Cash quality & payout

Operating cash flow / net income0.98x
Accruals ratio-2.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30
Income statement
Revenue$4.22M$3.05M
Cost of revenue$2.17M$1.81M
Gross profit$2.05M$1.25M
SG&A expense$10.50M$8.92M
Operating income-$12.61M-$10.68M
Interest expense$10,736$26,339
Net income-$12.43M-$10.57M
EBITDA-$11.44M-$9.47M
EPS (basic)-8.44-20.04
EPS (diluted)-8.44-20.04
Weighted avg. shares (diluted)1.47M527,364
Balance sheet
Cash & equivalents$3.99M$1.02M
Receivables$848,464$594,614
Inventory$418,577$635,215
Current assets$7.10M$4.14M
PP&E, net$294,399$251,325
Intangibles$2.80M$3.79M
Total assets$11.94M$8.25M
Current liabilities$4.93M$5.35M
Total liabilities$6.65M$5.44M
Shareholders' equity$5.51M$3.00M
Shares outstanding2.91M732,327
Cash flow statement
Operating cash flow-$11.93M-$9.68M
Capital expenditure$125,731$231,838
Free cash flow-$12.05M-$9.91M
Investing cash flow-$85,573-$231,838
Financing cash flow$14.98M$4.60M
Depreciation & amortization$1.16M$1.21M
Stock-based compensation$195,208$238,045

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.